{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,7,25]],"date-time":"2024-07-25T11:10:05Z","timestamp":1721905805796},"reference-count":37,"publisher":"Japanese Society of Veterinary Science","issue":"12","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["J. Vet. Med. Sci.","The Journal of Veterinary Medical Science"],"published-print":{"date-parts":[[2019]]},"DOI":"10.1292\/jvms.19-0043","type":"journal-article","created":{"date-parts":[[2019,10,21]],"date-time":"2019-10-21T22:05:17Z","timestamp":1571695517000},"page":"1722-1729","source":"Crossref","is-referenced-by-count":4,"title":["Melarsomine suppresses canine osteosarcoma cell survival via inhibition of Hedgehog-GLI signaling"],"prefix":"10.1292","volume":"81","author":[{"given":"Aryung","family":"NAM","sequence":"first","affiliation":[{"name":"Laboratory of Veterinary Internal Medicine, College of Veterinary Medicine, Seoul National University, Seoul 08826, Korea"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Taewon","family":"KIM","sequence":"additional","affiliation":[{"name":"Laboratory of Veterinary Pharmacology, College of Veterinary Medicine, Chungnam National University, Daejeon 34134, South Korea"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Qiang","family":"LI","sequence":"additional","affiliation":[{"name":"Laboratory of Veterinary Internal Medicine, College of Veterinary Medicine, Seoul National University, Seoul 08826, Korea"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Robert B.","family":"REBHUN","sequence":"additional","affiliation":[{"name":"Department of Surgical and Radiological Sciences, University of California Davis, School of Veterinary Medicine, Davis 95616, CA, U.S.A."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hwa-Young","family":"YOUN","sequence":"additional","affiliation":[{"name":"Laboratory of Veterinary Internal Medicine, College of Veterinary Medicine, Seoul National University, Seoul 08826, Korea"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kyoung-Won","family":"SEO","sequence":"additional","affiliation":[{"name":"Laboratory of Veterinary Internal Medicine, College of Veterinary Medicine, Chungnam National University, Daejeon 34134, Korea"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"122","reference":[{"key":"1","doi-asserted-by":"crossref","unstructured":"1. Beauchamp, E. M., Ringer, L., Bulut, G., Sajwan, K. P., Hall, M. D., Lee, Y. C., Peaceman, D., \u00d6zdemirli, M., Rodriguez, O., Macdonald, T. J., Albanese, C., Toretsky, J. A. and Uren, A. 2011. Arsenic trioxide inhibits human cancer cell growth and tumor development in mice by blocking Hedgehog\/GLI pathway. <i>J. Clin. Invest.<\/i> 121: 148\u2013160.","DOI":"10.1172\/JCI42874"},{"key":"2","doi-asserted-by":"crossref","unstructured":"2. Berg, J. 1996. Canine osteosarcoma: amputation and chemotherapy. <i>Vet. Clin. North Am. Small Anim. Pract.<\/i> 26: 111\u2013121.","DOI":"10.1016\/S0195-5616(96)50010-0"},{"key":"3","doi-asserted-by":"crossref","unstructured":"3. Boston, S. E., Ehrhart, N. P., Dernell, W. S., Lafferty, M. and Withrow, S. J. 2006. Evaluation of survival time in dogs with stage III osteosarcoma that undergo treatment: 90 cases (1985\u20132004). <i>J. Am. Vet. Med. Assoc.<\/i> 228: 1905\u20131908.","DOI":"10.2460\/javma.228.12.1905"},{"key":"4","doi-asserted-by":"crossref","unstructured":"4. Cai, X., Yu, K., Zhang, L., Li, Y., Li, Q., Yang, Z., Shen, T., Duan, L., Xiong, W. and Wang, W. 2015. Synergistic inhibition of colon carcinoma cell growth by Hedgehog-Gli1 inhibitor arsenic trioxide and phosphoinositide 3-kinase inhibitor LY294002. <i>Onco Targets Ther.<\/i> 8: 877\u2013883.","DOI":"10.2147\/OTT.S71034"},{"key":"5","doi-asserted-by":"crossref","unstructured":"5. Cavalcanti, J. N., Amstalden, E. M. I., Guerra, J. L. and Magna, L. C. 2004. Osteosarcoma in dogs: clinical-morphological study and prognostic correlation. <i>Braz. J. Vet. Res. Anim. Sci.<\/i> 41: 299\u2013305.","DOI":"10.1590\/S1413-95962004000500002"},{"key":"6","doi-asserted-by":"crossref","unstructured":"6. Chen, J. K., Taipale, J., Cooper, M. K. and Beachy, P. A. 2002. Inhibition of Hedgehog signaling by direct binding of cyclopamine to Smoothened. <i>Genes Dev.<\/i> 16: 2743\u20132748.","DOI":"10.1101\/gad.1025302"},{"key":"7","doi-asserted-by":"crossref","unstructured":"7. Ciociola, A. A., Cohen, L. B., Kulkarni, P. andFDA-Related Matters Committee of the American College of Gastroenterology. 2014. How drugs are developed and approved by the FDA: current process and future directions. <i>Am. J. Gastroenterol.<\/i> 109: 620\u2013623.","DOI":"10.1038\/ajg.2013.407"},{"key":"8","doi-asserted-by":"crossref","unstructured":"8. Dahmane, N. and Ruiz i Altaba, A. 1999. Sonic hedgehog regulates the growth and patterning of the cerebellum. <i>Development<\/i> 126: 3089\u20133100.","DOI":"10.1242\/dev.126.14.3089"},{"key":"9","doi-asserted-by":"crossref","unstructured":"9. Darzynkiewicz, Z., Bedner, E. and Smolewski, P. 2001. Flow cytometry in analysis of cell cycle and apoptosis. <i>Semin. Hematol.<\/i> 38: 179\u2013193.","DOI":"10.1053\/shem.2001.21929"},{"key":"10","doi-asserted-by":"crossref","unstructured":"10. Gustafson, T. L., Kitchell, B. E. and Biller, B. 2017. Hedgehog signaling is activated in canine transitional cell carcinoma and contributes to cell proliferation and survival. <i>Vet. Comp. Oncol.<\/i> 15: 174\u2013183.","DOI":"10.1111\/vco.12149"},{"key":"11","doi-asserted-by":"crossref","unstructured":"11. Han, J. B., Sang, F., Chang, J. J., Hua, Y. Q., Shi, W. D., Tang, L. H. and Liu, L. M. 2013. Arsenic trioxide inhibits viability of pancreatic cancer stem cells in culture and in a xenograft model via binding to SHH-Gli. <i>Onco Targets Ther.<\/i> 6: 1129\u20131138.","DOI":"10.2147\/OTT.S49148"},{"key":"12","doi-asserted-by":"crossref","unstructured":"12. Hirotsu, M., Setoguchi, T., Sasaki, H., Matsunoshita, Y., Gao, H., Nagao, H., Kunigou, O. and Komiya, S. 2010. Smoothened as a new therapeutic target for human osteosarcoma. <i>Mol. Cancer<\/i> 9: 5.","DOI":"10.1186\/1476-4598-9-5"},{"key":"13","doi-asserted-by":"crossref","unstructured":"13. Kerl, K., Moreno, N., Holsten, T., Ahlfeld, J., Mertins, J., Hotfilder, M., Kool, M., Bartelheim, K., Schleicher, S., Handgretinger, R., Sch\u00fcller, U., Meisterernst, M. and Fr\u00fchwald, M. C. 2014. Arsenic trioxide inhibits tumor cell growth in malignant rhabdoid tumors in vitro and in vivo by targeting overexpressed Gli1. <i>Int. J. Cancer<\/i> 135: 989\u2013995.","DOI":"10.1002\/ijc.28719"},{"key":"14","doi-asserted-by":"crossref","unstructured":"14. Kim, J., Lee, J. J., Kim, J., Gardner, D. and Beachy, P. A. 2010. Arsenic antagonizes the Hedgehog pathway by preventing ciliary accumulation and reducing stability of the Gli2 transcriptional effector. <i>Proc. Natl. Acad. Sci. U.S.A.<\/i> 107: 13432\u201313437.","DOI":"10.1073\/pnas.1006822107"},{"key":"15","doi-asserted-by":"crossref","unstructured":"15. Langenbach, A., Anderson, M. A., Dambach, D. M., Sorenmo, K. U. and Shofer, F. D. 1998. Extraskeletal osteosarcomas in dogs: a retrospective study of 169 cases (1986\u20131996). <i>J. Am. Anim. Hosp. Assoc.<\/i> 34: 113\u2013120.","DOI":"10.5326\/15473317-34-2-113"},{"key":"16","doi-asserted-by":"crossref","unstructured":"16. List, A., Beran, M., DiPersio, J., Slack, J., Vey, N., Rosenfeld, C. S. and Greenberg, P. 2003. Opportunities for Trisenox (arsenic trioxide) in the treatment of myelodysplastic syndromes. <i>Leukemia<\/i> 17: 1499\u20131507.","DOI":"10.1038\/sj.leu.2403021"},{"key":"17","doi-asserted-by":"crossref","unstructured":"17. Liu, J. T. and Bain, L. J. 2014. Arsenic inhibits hedgehog signaling during P19 cell differentiation. <i>Toxicol. Appl. Pharmacol.<\/i> 281: 243\u2013253.","DOI":"10.1016\/j.taap.2014.10.007"},{"key":"18","doi-asserted-by":"crossref","unstructured":"18. Lo, W. W., Pinnaduwage, D., Gokgoz, N., Wunder, J. S. and Andrulis, I. L. 2014. Aberrant hedgehog signaling and clinical outcome in osteosarcoma. <i>Sarcoma<\/i> 2014: 261804.","DOI":"10.1155\/2014\/261804"},{"key":"19","unstructured":"19. Moore, A. S., Dernell, W. S., Ogilvie, G. K., Kristal, O., Elmslie, R., Kitchell, B., Susaneck, S., Rosenthal, R., Klein, M. K., Obradovich, J., Legendre, A., Haddad, T., Hahn, K., Powers, B. E. and Warren, D. 2007. Doxorubicin and BAY 12-9566 for the treatment of osteosarcoma in dogs: a randomized, double-blind, placebo-controlled study. <i>J. Vet. Intern. Med.<\/i> 21: 783\u2013790."},{"key":"20","doi-asserted-by":"crossref","unstructured":"20. Nagao-Kitamoto, H., Nagata, M., Nagano, S., Kitamoto, S., Ishidou, Y., Yamamoto, T., Nakamura, S., Tsuru, A., Abematsu, M., Fujimoto, Y., Yokouchi, M., Kitajima, S., Yoshioka, T., Maeda, S., Yonezawa, S., Komiya, S. and Setoguchi, T. 2015. GLI2 is a novel therapeutic target for metastasis of osteosarcoma. <i>Int. J. Cancer<\/i> 136: 1276\u20131284.","DOI":"10.1002\/ijc.29107"},{"key":"21","doi-asserted-by":"crossref","unstructured":"21. Nakamura, S., Nagano, S., Nagao, H., Ishidou, Y., Yokouchi, M., Abematsu, M., Yamamoto, T., Komiya, S. and Setoguchi, T. 2013. Arsenic trioxide prevents osteosarcoma growth by inhibition of GLI transcription via DNA damage accumulation. <i>PLoS One<\/i> 8: e69466.","DOI":"10.1371\/journal.pone.0069466"},{"key":"22","doi-asserted-by":"crossref","unstructured":"22. Oblak, M. L., Boston, S. E., Higginson, G., Patten, S. G., Monteith, G. J. and Woods, J. P. 2012. The impact of pamidronate and chemotherapy on survival times in dogs with appendicular primary bone tumors treated with palliative radiation therapy. <i>Vet. Surg.<\/i> 41: 430\u2013435.","DOI":"10.1111\/j.1532-950X.2012.00968.x"},{"key":"23","unstructured":"23. Pathi, S., Pagan-Westphal, S., Baker, D. P., Garber, E. A., Rayhorn, P., Bumcrot, D., Tabin, C. J., Blake Pepinsky, R. and Williams, K. P. 2001. Comparative biological responses to human Sonic, Indian, and Desert hedgehog. <i>Mech. Dev.<\/i> 106: 107\u2013117."},{"key":"24","doi-asserted-by":"crossref","unstructured":"24. Phillips, B., Powers, B. E., Dernell, W. S., Straw, R. C., Khanna, C., Hogge, G. S. and Vail, D. M. 2009. Use of single-agent carboplatin as adjuvant or neoadjuvant therapy in conjunction with amputation for appendicular osteosarcoma in dogs. <i>J. Am. Anim. Hosp. Assoc.<\/i> 45: 33\u201338.","DOI":"10.5326\/0450033"},{"key":"25","unstructured":"25. Plumb, D. C. 2018. Plumb\u2019s Veterinary Drug Handbook. John Wiley &amp; Sons, Hoboken."},{"key":"26","doi-asserted-by":"crossref","unstructured":"26. Rahnama, F., Shimokawa, T., Lauth, M., Finta, C., Kogerman, P., Teglund, S., Toftg\u00e5rd, R. and Zaphiropoulos, P. G. 2006. Inhibition of GLI1 gene activation by Patched1. <i>Biochem. J.<\/i> 394: 19\u201326.","DOI":"10.1042\/BJ20050941"},{"key":"27","doi-asserted-by":"crossref","unstructured":"27. Rimkus, T. K., Carpenter, R. L., Qasem, S., Chan, M. and Lo, H. W. 2016. Targeting the sonic hedgehog signaling pathway: Review of smoothened and GLI inhibitors. <i>Cancers (Basel)<\/i> 8: 22.","DOI":"10.3390\/cancers8020022"},{"key":"28","doi-asserted-by":"crossref","unstructured":"28. Shahi, M. H., Holt, R. and Rebhun, R. B. 2014. Blocking signaling at the level of GLI regulates downstream gene expression and inhibits proliferation of canine osteosarcoma cells. <i>PLoS One<\/i> 9: e96593.","DOI":"10.1371\/journal.pone.0096593"},{"key":"29","doi-asserted-by":"crossref","unstructured":"29. Sleigh, S. H. and Barton, C. L. 2010. Repurposing strategies for therapeutics. <i>Pharmaceut. Med.<\/i> 24: 151\u2013159.","DOI":"10.1007\/BF03256811"},{"key":"30","doi-asserted-by":"crossref","unstructured":"30. Spodnick, G. J., Berg, J., Rand, W. M., Schelling, S. H., Couto, G., Harvey, H. J., Henderson, R. A., MacEwen, G., Mauldin, N., McCaw, D. L., et al. 1992. Prognosis for dogs with appendicular osteosarcoma treated by amputation alone: 162 cases (1978\u20131988). <i>J. Am. Vet. Med. Assoc.<\/i> 200: 995\u2013999.","DOI":"10.2460\/javma.1992.200.07.995"},{"key":"31","doi-asserted-by":"crossref","unstructured":"31. Szewczyk, M., Lechowski, R. and Zabielska, K. 2015. What do we know about canine osteosarcoma treatment? Review. <i>Vet. Res. Commun.<\/i> 39: 61\u201367.","DOI":"10.1007\/s11259-014-9623-0"},{"key":"32","doi-asserted-by":"crossref","unstructured":"32. Thompson, K. G. and Pool, R. R. 2002. Tumors of bones. pp. 245\u2013318. <i>In<\/i>: Tumors in Domestic Animals, 4th ed. (Meuten, d. J. ed.), Iowa State Press, Ames.","DOI":"10.1002\/9780470376928.ch5"},{"key":"33","doi-asserted-by":"crossref","unstructured":"33. Varjosalo, M. and Taipale, J. 2008. Hedgehog: functions and mechanisms. <i>Genes Dev.<\/i> 22: 2454\u20132472.","DOI":"10.1101\/gad.1693608"},{"key":"34","doi-asserted-by":"crossref","unstructured":"34. Warzecha, J., G\u00f6ttig, S., Chow, K. U., Br\u00fcning, C., Percic, D., Boehrer, S., Brude, E. and Kurth, A. 2007. Inhibition of osteosarcoma cell proliferation by the Hedgehog-inhibitor cyclopamine. <i>J. Chemother.<\/i> 19: 554\u2013561.","DOI":"10.1179\/joc.2007.19.5.554"},{"key":"35","doi-asserted-by":"crossref","unstructured":"35. Wiebe, V. J. 2015. Chapter 192: melarsomine. pp. 265\u2013267. <i>In<\/i>: Drug Therapy for Infectious Diseases of the Dog and Cat, John Wiley &amp; Sons, Inc., Hoboken.","DOI":"10.1002\/9781118911167"},{"key":"36","doi-asserted-by":"crossref","unstructured":"36. Yang, D., Cao, F., Ye, X., Zhao, H., Liu, X., Li, Y., Shi, C., Wang, H. and Zhou, J. 2013. Arsenic trioxide inhibits the Hedgehog pathway which is aberrantly activated in acute promyelocytic leukemia. <i>Acta Haematol.<\/i> 130: 260\u2013267.","DOI":"10.1159\/000351603"},{"key":"37","doi-asserted-by":"crossref","unstructured":"37. You, M., Varona-Santos, J., Singh, S., Robbins, D. J., Savaraj, N. and Nguyen, D. M. 2014. Targeting of the Hedgehog signal transduction pathway suppresses survival of malignant pleural mesothelioma cells in vitro. <i>J. Thorac. Cardiovasc. Surg.<\/i> 147: 508\u2013516.","DOI":"10.1016\/j.jtcvs.2013.08.035"}],"container-title":["Journal of Veterinary Medical Science"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/jvms\/81\/12\/81_19-0043\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,7,25]],"date-time":"2024-07-25T10:37:17Z","timestamp":1721903837000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/jvms\/81\/12\/81_19-0043\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019]]},"references-count":37,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2019]]}},"URL":"https:\/\/doi.org\/10.1292\/jvms.19-0043","relation":{},"ISSN":["0916-7250","1347-7439"],"issn-type":[{"value":"0916-7250","type":"print"},{"value":"1347-7439","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019]]}}}